Ledger.Open graph →
SEC Form D · filed May 31, 2017

AntriaBio, Inc

Offering
$15.0M
Sold
$6.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LOUISVILLE, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (31)

Nevan C. Elam · Louisville, COExec · DirectorHoyoung C. Huh · Louisville, COExec · DirectorMorgan L. Fields · Louisville, COExecTae H. Kim · Louisville, CODirectorSamir R. Patel · Louisville, CODirectorSankaram R. Mantripragada · Louisville, COExecMichael R. Deperro · Louisville, COExecDavid F. Welch · Louisville, CODirectorBrian R. Roberts · Louisville, COExecBarry C. Sherman · Louisville, CODirectorNoopur B. Liffick · Louisville, COExecMadeline Hwang · LAS VEGAS, NVExec · DirectorGeoffrey P. Jacobs · Scottsdale, AZDirectorRyan Reich · Philadelphia, PAExecAlbert J. Yu · New York, NYExecKristy Campbell · Dallas, TXDirectorDavid J. Renas · New York, NYExecCarmen Pavlovic · NEW YORK, NYDirectorCarrie P. Holloway · LAS VEGAS, NVExec · DirectorKimball P. Holloway · LAS VEGAS, NVExecSangam Sogani · New York, NYExec · DirectorDonald Brennan · Brooklyn, NYExecJason Pappas · Baltimore, MDDirectorRehan Jaffer · New York, NYExecChristopher E. Galvin · Scottsdale, AZDirectorJames M. Willett · Mettawa, ILExecKevin M. Blonkvist, Jr · Midland, TXExecMikael E. Taipale · Espoo, H9ExecTracey B. Bracco · Orlando, FLDirectorMatthew K. Schatzman · THE WOODLANDS, TXDirectorGoodwin T. George · Nashville, TNExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗